Stocksigma LogoStocksigma Logo

CARE Ratings Issues Q2FY27 Monitoring Agency Report for KIMS Preferential Warrant Issue

CARE Ratings confirmed zero fund utilization during Q2FY27 from the ₹150 crore upfront warrant subscription money received on 19th Aug'26 out of KIMS's

CARE Ratings Issues Q2FY27 Monitoring Agency Report for KIMS Preferential Warrant Issue

Krishna Institute of Medical Sciences Ltd · Others (Uncategorized) · 05 Nov 2026, 2:25 am

CARE Ratings Issues Q2FY27 Monitoring Agency Report for KIMS Preferential Warrant Issue CARE Ratings confirmed zero fund utilization during Q2FY27 from the ₹150 crore upfront warrant subscription money received on 19th Aug'26 out of KIMS's ₹600 crore preferential issue to promoters. The unutilized ₹150 crore is temporarily parked in liquid funds, money market funds, and bank accounts (valued at ₹150.96 crore as of 30th Sep'26). The balance ₹450 crore is receivable upon conversion by 18th Feb'28. CARE flagged conversion risk as KIMS's CMP of ₹730.50 (3rd Nov'26) traded below the warrant exercise price of ₹779.00.

Original exchange filing (PDF)

More announcements from Krishna Institute of Medical Sciences Ltd

All Krishna Institute of Medical Sciences Ltd announcements